Filtricine
Latest round
- Seed
Last raised
- Aug 2022
Total raised
- Undisclosed
Investors
- 2
About Filtricine
Filtricine, Inc. is a health-focused company developing Tality, a nutritional product aimed at supporting cancer patients during treatment.Filtricine, Inc. was founded in 2017 in Sunnyvale, US, and specializes in clinical nutrition for cancer patients. The company is co-founded by Grace Yang and Xin Wang, with John Chant serving as CEO.Filtricine, Inc. specializes in developing Tality, a revolutionary food product currently undergoing clinical investigation for cancer treatment. Tality is designed as a proprietary nutritional regimen of meal replacements that deprives cancer cells of non-essential amino acids while preserving essential nutrients. This innovative approach is being tested in clinical trials, particularly for prostate cancer patients at Stanford University School of Medicine, and is available at no cost to participating cancer patients.Filtricine generates revenue through its clinical trial programs and partnerships with healthcare providers involved in cancer care. Its flagship product, Tality, is distributed through clinical trials, allowing patients to access it at no cost while contributing to research.Filtricine, Inc. The company is focusing on expanding its reach within the North American market, particularly aiming to establish partnerships with additional oncology specialists and healthcare systems. As Tality progresses through its clinical trial phases, Filtricine anticipates potential revenue growth through expanded distribution channels and strategic collaborations.
Who invested in Filtricine
2 investors across 4 rounds
See all investors in Filtricine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Filtricine
Who invested in Filtricine?
Filtricine has 2 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Filtricine raised?
Filtricine has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Filtricine last raise money?
Filtricine's most recent round on record is a Seed, in Aug 2022.
What does Filtricine do?
Filtricine is a healthcare specialists company.
Where is Filtricine headquartered?
Filtricine is headquartered in Sunnyvale, US.
Which VCs invest in companies like Filtricine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Filtricine's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like Filtricine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.